The campaign arrives at a critical juncture in oncology. While advancements in screening have improved survival rates for early-stage diagnoses, metastatic breast cancer—also known as Stage 4—remains an incurable condition. For the estimated 42,670 Americans expected to die from the disease in 2026, the traditional "pink" messaging often feels incomplete. #LightUpMBC seeks to bridge this gap, transforming awareness into tangible research funding and honoring the 117 lives lost to the disease every single day in the United States.
Main Facts: A Global Radiance for Research
The #LightUpMBC campaign is not merely a visual spectacle; it is a strategic effort to redirect the public’s attention toward the only form of breast cancer that kills. Unlike early-stage breast cancer, which is confined to the breast or regional lymph nodes, metastatic breast cancer occurs when the disease spreads to vital organs, most commonly the bones, liver, lungs, or brain.
The 2026 campaign is set to be the largest in history. Participating landmarks include architectural marvels such as One World Trade Center in New York City, the Willis Tower in Chicago, and Philadelphia City Hall. The reach extends far beyond American borders, encompassing Niagara Falls on the North American frontier, the Ness Bridge in Inverness, Scotland, and the Mactan-Cebu International Airport in the Philippines.
Each of these sites will glow in teal, green, and pink—the official colors of the MBC awareness ribbon. Each color carries a specific symbolism: teal represents healing and spirituality; green symbolizes the triumph of spring over winter and the renewal of life; and pink signifies the breast cancer origin.
The centerpiece of the evening is #LightUpMBC Live, a free virtual broadcast beginning at 8 p.m. ET. Hosted by Tami Eagle Bowling, a veteran advocate living with MBC for 11 years, and Broadway star Kara Lindsay, the program serves as a digital town hall. It will feature a blend of patient testimonials, scientific updates from leading oncologists, and performances by Tony Award-winning artists, all aimed at fostering a sense of community for a population that often feels isolated by their diagnosis.
Chronology: From a Single Bridge to a Global Beacon
The origins of #LightUpMBC are rooted in a personal story of friendship and loss. The campaign was founded by Laura Inahara in memory of her best friend, Jessica Moore. In 2017, Moore was living with metastatic breast cancer at the age of 36. Her modest hope was to see a single local landmark—the Memorial Bridge in Portsmouth, New Hampshire—lit in the MBC colors to acknowledge those living with the terminal stage of the disease.
Moore passed away before she could see the movement reach its current scale, but her legacy became the catalyst for a rapid international expansion. What began as a localized tribute in New Hampshire quickly resonated with the MBC community, which had long felt sidelined during Breast Cancer Awareness Month.
By 2019, the campaign had expanded to dozens of cities. By the early 2020s, it had crossed oceans. To date, the #LightUpMBC initiative has raised over $2.7 million, with 100% of net proceeds directed toward Stage 4 research. The chronology of the movement reflects a growing restlessness among patients who are no longer satisfied with "awareness" alone; they are demanding the scientific breakthroughs necessary to extend their lives.
Supporting Data: The Stark Reality of Stage 4
To understand the urgency behind the #LightUpMBC campaign, one must look at the data surrounding metastatic disease. While breast cancer is often framed as a "survivable" illness, the statistics for Stage 4 patients tell a more complex story.
- Mortality Rates: In 2026, the American Cancer Society and SEER (Surveillance, Epidemiology, and End Results) program data estimate that 42,670 people will die from breast cancer in the U.S. This equates to approximately 117 deaths per day, or one death every 12 minutes. Nearly all of these deaths are the result of metastatic disease.
- The Funding Gap: Historically, only a small fraction of overall breast cancer research funding (estimated between 7% and 15% globally) is dedicated specifically to metastatic disease. The vast majority of funding is directed toward prevention, early detection, and early-stage treatment. METAvivor was founded specifically to address this disparity, ensuring that 100% of its research grants go to Stage 4 projects.
- The "Hidden" Population: It is estimated that over 168,000 women in the U.S. are currently living with metastatic breast cancer. This number is increasing, not because more people are being diagnosed, but because research-driven treatments are allowing patients to live longer with the disease.
- Recurrence vs. De Novo: While some patients are diagnosed "de novo" (at Stage 4 from the start), many others develop metastatic disease years or even decades after being told they were "cancer-free." This reality underscores the fact that "finishing treatment" does not always mean the threat has been eliminated.
Official Responses: Advocacy and the Hope for a Cure
The leadership at METAvivor emphasizes that while the lights are beautiful, the mission is biological. Dr. Kelly Shanahan, the Board President of METAvivor and a physician herself, has been living with MBC since 2013. Her perspective bridges the gap between clinical knowledge and the patient experience.
"When I was diagnosed in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan stated. "My hope, and the hope of so many others, lies in research. METAvivor-funded research is increasingly important because it focuses specifically on how to stop the spread and how to treat cancer once it has moved. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
Laura Inahara, the campaign’s founder, views the global participation as a fulfillment of Jessica Moore’s vision. "Jessica’s legacy helps families around the world shine a light for the people they love," Inahara said. "It teaches patients with MBC how to advocate for themselves. Raising $2.7 million is a milestone, but the ultimate goal is to fund the research that makes this disease a chronic, manageable condition rather than a terminal one."
The scientific community also plays a pivotal role in the campaign. During the #LightUpMBC Live broadcast, researchers will provide insights into the current state of clinical trials, including the development of antibody-drug conjugates (ADCs) and immunotherapy, which have shown promise in treating specific subtypes of metastatic disease, such as Triple-Negative and HER2-positive MBC.
Implications: Shifting the Narrative from Awareness to Action
The implications of the #LightUpMBC campaign extend far beyond a single night in October. It represents a paradigm shift in how the public perceives breast cancer. For decades, the "pink ribbon" era focused heavily on the "warrior" and "survivor" tropes, which often emphasize a clear beginning and end to the cancer journey.
For the metastatic community, there is no "end" to treatment. The implication of #LightUpMBC is a demand for a more nuanced public discourse—one that acknowledges that "early detection" is not a guarantee of a cure and that "no evidence of disease" (NED) is often a temporary reprieve rather than a permanent state.
Furthermore, the campaign highlights the power of patient-led philanthropy. By utilizing a rigorous scientific peer-review process that includes both medical experts and patient advocates, METAvivor ensures that the research being funded is directly relevant to the needs of those living with the disease. This model of "patient-centric research" is increasingly seen as a blueprint for other terminal illnesses.
As the landmarks dim their lights on the morning of October 14, the work continues. The funds raised during the 2026 campaign will be converted into research grants awarded in the following year. The ultimate implication of the #LightUpMBC movement is the belief that through targeted funding and global solidarity, Stage 4 breast cancer can eventually be transformed from a death sentence into a survivable, long-term condition.
For now, the world waits for October 13, when the glow of teal, green, and pink will serve as a reminder that while the disease is metastatic, the hope for a cure is equally expansive.
How to Participate:
The public is encouraged to visit www.lightupmbc.org to find a map of participating landmarks. Supporters can join the conversation on social media by using the hashtags #LightUpMBC and #METAvivor, and by tuning into the live stream on October 13 at 8 p.m. ET via METAvivor’s YouTube and Facebook channels.
About the Author
